Publications
Found 22 results
Filters: Keyword is Disease Models, Animal [Clear All Filters]
"Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection.",
Cell Host Microbe, vol. 20, issue 4, pp. 482-492, 2016 Oct 12.
"NK-, NKT- and CD8-Derived IFNγ Drives Myeloid Cell Activation and Erythrophagocytosis, Resulting in Trypanosomosis-Associated Acute Anemia.",
PLoS Pathog, vol. 11, issue 6, pp. e1004964, 2015 Jun.
"Specific Cell Targeting Therapy Bypasses Drug Resistance Mechanisms in African Trypanosomiasis.",
PLoS Pathog, vol. 11, issue 6, pp. e1004942, 2015 Jun.
"Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies.",
Leukemia, vol. 28, issue 2, pp. 444-7, 2014 Feb.
"Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis.",
J Nucl Med, vol. 55, issue 5, pp. 824-9, 2014 May.
"Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.",
J Virol, vol. 88, issue 15, pp. 8278-96, 2014 Aug.
"A bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymes.",
Nat Biotechnol, vol. 30, issue 12, pp. 1225-31, 2012 Dec.
"In situ microscopy analysis reveals local innate immune response developed around Brucella infected cells in resistant and susceptible mice.",
PLoS Pathog, vol. 8, issue 3, pp. e1002575, 2012.
"Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions.",
Circ Res, vol. 110, issue 7, pp. 927-37, 2012 Mar 30.
"Mouse models for pathogenic African trypanosomes: unravelling the immunology of host-parasite-vector interactions.",
Parasite Immunol, vol. 33, issue 8, pp. 423-9, 2011 Aug.
"Vaccination against trypanosomiasis: can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist?",
Hum Vaccin, vol. 7, issue 11, pp. 1225-33, 2011 Nov.
"Contributions of experimental mouse models to the understanding of African trypanosomiasis.",
Trends Parasitol, vol. 24, issue 9, pp. 411-8, 2008 Sep.
"Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex.",
PLoS One, vol. 3, issue 4, pp. e2040, 2008.
"Role of iron homeostasis in trypanosomiasis-associated anemia.",
Immunobiology, vol. 213, issue 9-10, pp. 823-35, 2008.
"Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responses.",
PLoS Pathog, vol. 4, issue 5, pp. e1000078, 2008 May.
"Control of Trypanosoma evansi infection is IgM mediated and does not require a type I inflammatory response.",
J Infect Dis, vol. 195, issue 10, pp. 1513-20, 2007 May 15.
"A glycosylphosphatidylinositol-based treatment alleviates trypanosomiasis-associated immunopathology.",
J Immunol, vol. 179, issue 6, pp. 4003-14, 2007 Sep 15.
"Interleukin-12p70-dependent interferon- gamma production is crucial for resistance in African trypanosomiasis.",
J Infect Dis, vol. 196, issue 8, pp. 1253-60, 2007 Oct 15.
"Interferon-gamma and nitric oxide in combination with antibodies are key protective host immune factors during trypanosoma congolense Tc13 Infections.",
J Infect Dis, vol. 193, issue 11, pp. 1575-83, 2006 Jun 1.
"Tsetse fly saliva accelerates the onset of Trypanosoma brucei infection in a mouse model associated with a reduced host inflammatory response.",
Infect Immun, vol. 74, issue 11, pp. 6324-30, 2006 Nov.
"P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis.",
J Infect Dis, vol. 189, issue 3, pp. 527-39, 2004 Feb 1.
"Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections.",
Infect Immun, vol. 67, issue 6, pp. 3128-32, 1999 Jun.